Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone

NCT00600756 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

798

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenic Disorders

Interventions

DRUG: Quetiapine XR
DRUG: Risperidone

Sponsor

AstraZeneca